Curcumin prevents ICH-induced inflammatory molecules through NF-魏B activation via the p38MAPK/PKC pathway in vitro.
Curcumin protects hippocampal HT22 cells from indirect toxicity mediated by ICH-treated microglial cells.
Curcumin attenuates ICH-induced neurological deficit and cerebral water content in vivo.
Curcumin represent a novel herbal sources for ICH therapeutical strategy.